Stockreport

Chronic Refractory Cough Pipeline Landscape Report 2024 Featuring GSK and Trevi Therapeutics [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF Understanding Chronic Refractory Cough CRC presents a unique challenge within the medical community. Characterized by a persistent cough lasting more than eight weeks [Read more]